Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Defy Medical vs Primary Clinic (Direct GLP)

Defy Medical
Graded #326

Lower grade

vs+8.5
Primary Clinic (Direct GLP)
Graded #144

Higher grade

The verdict

Primary Clinic (Direct GLP) takes it — 68.7/100 to 60.2/100.

Primary Clinic (Direct GLP) grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Primary Clinic (Direct GLP) is a Direct Primary Care membership rather than the usual direct-to-consumer GLP-1 marketplace.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePrimary Clinic (Direct GLP) +33
45
78
Dose & formulationDefy Medical +2
56
54
Clinical oversightDefy Medical +5
80
75
Labs & monitoringPrimary Clinic (Direct GLP) +11
65
76
FulfillmentPrimary Clinic (Direct GLP) +10
63
73
Contract termsDefy Medical +14
55
41
Defy Medical · left barPrimary Clinic (Direct GLP) · right bar

The numbers

MetricDefy MedicalPrimary Clinic (Direct GLP)
WeighScore60.2/10068.7/100
GradeCC
Scorecard rank#326#144
SemaglutideNot disclosed$65/mo (0.25 mg dose, promotional rate, compounded)
TirzepatideNot disclosed$110/mo (2.5 mg dose, promotional rate, compounded)
CoverageCoverage not published10 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Defy Medical

Graded #326 · C

Strengths

  • Multiple GLP-1 options: semaglutide, tirzepatide, liraglutide
  • Offers injection, ODT, and oral drop delivery forms
  • Comprehensive blood testing and named medical director
  • Established clinic with strong Trustpilot review volume

Where it loses points

  • GLP-1 pricing not published on the website
  • States served and shipping limits not disclosed
  • Compounded versus brand status not stated online
  • Lab-heavy, consult-first model may cost more upfront

Strengths

  • Direct Primary Care model integrates GLP-1 with continuous primary care — unlike most direct-to-consumer platforms
  • GLP-1 at wholesale cost with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
  • Unlimited primary care visits, direct text access, and same-day care bundled in the $89/mo membership
  • Routine labs and thousands of medications included in membership — no surprise bills
  • Per-dose pricing shown publicly for all 8 dose tiers of both semaglutide and tirzepatide

Where it loses points

  • 10 states only (WA, NM, AZ, UT, FL, DC, KS, OK, VA, GA) — limited vs 50-state platforms
  • Membership required to access wholesale pricing — $89/mo adds ~$1,068/yr in fixed cost
  • 503A pharmacy partners not named
  • LegitScript certification not mentioned on the site
  • Medical director and corporate legal entity not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard